Concepedia

Gabriela R. Rossi

GR

13

Publications

458

Citations

11

H-Index

1998

Active since

Affiliations

NewLink Genetics (United States)(Current)

National Foundation for Cancer Research

Cancer Research Foundation

Huntsman Cancer Institute

Universidad Nacional de Córdoba

Gabriela R. Rossi is an author at NewLink Genetics (United States) specializing in medicine, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

1998–2023

13

Publications

13

Phase II trial of the IDO pathway inhibitor indoximod plus pembrolizumab for the treatment of patients with advanced melanoma

Yousef Zakharia, Robert R. McWilliams, Olivier Rixe et al. · Journal for ImmunoTherapy of Cancer · 2021 · 85 citations · Full text

Effective Treatment of Preexisting Melanoma with Whole Cell Vaccines Expressing α(1,3)-Galactosyl Epitopes

Gabriela R. Rossi, Mario R. Mautino, Robert C. Unfer et al. · Cancer Research · 2005 · 75 citations

Potential role for excretory–secretory forms of glutathione-S-transferase (GST) in <i>Fasciola hepatica</i>

Laura Cervi, Gabriela R. Rossi, Diana T. Masih · Parasitology · 1999 · 69 citations

, , +23

Immunotherapy updates in pancreatic cancer: are we there yet?

Krishna S. Gunturu, Gabriela R. Rossi, Muhammad Wasif · Therapeutic Advances in Medical Oncology · 2012 · 42 citations · Full text

, , +12

Phase 2 trial of the IDO pathway inhibitor indoximod plus gemcitabine / nab-paclitaxel for the treatment of patients with metastatic pancreas cancer.

Nathan Bahary, Andrea Wang‐Gillam, Sigurdís Haraldsdóttir et al. · Journal of Clinical Oncology · 2018 · 39 citations

, , +16

Rows per page

1–5 of 13